503 — Lansen Pharmaceutical Holdings Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeSmall Cap
- HK$750.60m
- HK$527.08m
- $65.56m
Brief: Lansen Pharmaceutical Says Ningbo Liwah Entered Settlement Agreement
Brief: Lansen Pharmaceutical updates on share reduction plan of Zhejiang Starry Pharmaceutical
Brief: Lansen Pharma updates on litigation against Ningbo Liwah unit
Brief: Lansen Pharmaceutical Holdings says HY revenue $50.5 mln
Brief: Lansen Pharmaceutical Holdings says board declared a special dividend of hk14.94 cents per share
Brief: Lansen Pharmaceutical appoints Wu Zhen Tao as chairman
Brief: Lansen Pharmaceutical updates on disposal of Starry shares
Brief: Lansen Pharmaceutical says unit entered into framework agreement with Natural Dailyheath
Brief: Lansen Pharmaceutical appoints Hou Song as the executive director
Brief: Lansen Pharmaceutical enters into subscription agreement
Brief: Lansen pharmaceutical issues profit warning
Brief: Lansen Pharmaceutical updates on approval for Zhejiang Starry Pharmaceutical IPO
Brief: Lansen Pharma updates on adminstrative penalty imposed on Ningbo Liwah
Brief: Lansen Pharmaceutical unit enters asset purchase agreement with Novartis